Oral Contraceptive Rx-to-OTC Switch On The Cusp In UK
The MHRA is consulting on two Rx-to-OTC switch applications for progestogen-only contraceptive pills containing desogestrel, one from HRA Pharma and one from Maxwellia. The move has been welcomed by UK consumer healthcare industry association, the PAGB, as well as the British Pregnancy Advisory Service.
You may also be interested in...
As calls for a non-prescription daily contraceptive pill grow in the UK, switch incubator Maxwellia suggests an Rx-to-OTC reclassification of the widely-used progestogen only pill may be one of its first "switch-in-a-box" projects.
UK parliamentarians have added their voice to the growing calls for the MHRA to switch the daily oral contraceptive pill to OTC status. The COVID-19 pandemic has further highlighted the difficulties women face in accessing contraception, according to the politicians.
Make Emergency Contraceptives GSL In The UK, Urge HRA Pharma And The British Pregnancy Advisory Service
EllaOne manufacturer HRA Pharma supports the British Pregnancy Advisory Service's (BPAS') calls to scrap mandatory consultations for emergency contraceptives by switching these medicines from pharmacy-only to general sales list status.